Dienogest is one of 60 small molecule programs targeting Dysmenorrhea. It is currently in Phase 3.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
37 competitors in Contraception
Jadelle
Tivicay
Cytotec
Estrace
Implanon
Pletal
Orgovyx
Jatenzo
Imdur
Ultram
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Sources